Shapiro, Daniel Mark http://orcid.org/0000-0002-8327-2911
Mandava, Gunasheil
Yalcin, Sibel Ebru http://orcid.org/0000-0002-6041-5297
Arranz-Gibert, Pol
Dahl, Peter J.
Shipps, Catharine http://orcid.org/0000-0001-8397-1096
Gu, Yangqi http://orcid.org/0000-0002-8206-8804
Srikanth, Vishok http://orcid.org/0000-0003-2498-4641
Salazar-Morales, Aldo I. http://orcid.org/0000-0002-8126-9460
O’Brien, J. Patrick
Vanderschuren, Koen
Vu, Dennis http://orcid.org/0000-0002-2623-963X
Batista, Victor S. http://orcid.org/0000-0002-3262-1237
Malvankar, Nikhil S. http://orcid.org/0000-0001-5611-6633
Isaacs, Farren J. http://orcid.org/0000-0001-8615-8236
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (1DP2AI138259-01, RO1GM1404810)
National Science Foundation (1749662, MCB-1714860)
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 22 October 2021
Accepted: 13 January 2022
First Online: 11 February 2022
Competing interests
: D.M.S., S.E.Y., N.S.M. and F.J.I. are named inventors on a patent application filed by Yale University (U.S.S.N. 63/302,932) covering the methods of making and using engineered FimA proteins encoded with metal nanoparticles. F.J.I. is a co-founder at Pearl Bio. The remaining authors declare no competing interests.